Table 3 Efficacy outcome for ASAQ and AL on day 42, calculated by PP analysis and Kaplan-Meier analysis

PCR unadjusted

n/N

13/131

19/125

12/156

18/145

% efficacy [CI95%]

90.1 [83.6-94.6]

84.8 [77.3-90.6]

90.9 [84.6-94.8]

85.8 [78.4-90.8]

% difference (LLCI*)

−5.2 (−0.02)

PCR adjusted

n/N

2/120

1/107

2/146

1/137

% efficacy [CI95%]

98.3 [94.1-99.8]

99.1 [94.9-99.9]

98.4 [93.8-99.6]

99.2 [94.3-99.9]

% difference (LLCI*)

−0.7 (−3.1)